AbCellera Biologics Inc. ABCL
$5.22
▼ -0.57% 24H
About
AbCellera Biologics Inc. is a biotechnology company based in Vancouver, Canada, focused on discovering and developing therapeutic antibodies. The company operates a technology-driven antibody discovery platform that integrates biology, computation, and engineering to identify drug candidates from natural immune respons…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryCanada
Employees596
TickerABCL
Statistics
Market Cap$1.59B
Revenue (TTM)$75.1M
Net Income-$146.4M
Net Margin-194.9%
EPS$-0.49
P/E-10.68
P/S20.32
P/B1.71
EV/EBITDA-6.29
ROE-14.7%
Dividend Yield—
Price$5.22
Data: Twelve Data · Revenue = mcap / P/S